Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival?

Title
Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival?
Authors
Keywords
-
Journal
CANCER
Volume 115, Issue 19, Pages 4477-4487
Publisher
Wiley
Online
2009-08-18
DOI
10.1002/cncr.24484

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started